Jorge Ramos, D.O.

Associate Vice President, Clinical Development

Jorge leads program-specific medical monitoring, protocol development, and the clinical development plan strategy and execution for FOG-001, Parabilis Medicines’ lead program. Prior to joining Parabilis, he was Executive Medical Director and Global Development Lead in Late-Stage Clinical Development at Pfizer. There, he provided strategic oversight of a program with multiple registrational trials in breast and colorectal cancer. Prior to Pfizer, he worked on several clinical trials across multiple phases of clinical development in solid tumor oncology at Seagen. Prior to industry, he was an Assistant Professor at the University of Washington’s Fred Hutchinson Cancer Center, focusing on adoptive T-cell therapies in hematologic malignancies and solid tumors. He completed his internal medicine residency at Yale University and subspecialty training in hematology and oncology at the University of Washington’s Fred Hutchinson Cancer Center. Jorge holds a D.O. from the University of Medicine and Dentistry of New Jersey and a B.A. from Rutgers University.